Replies to post #42755 on Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

I’m just going to put these two papers here to cheer you all up. Enjoy! Read the PNAS one first, then read the nature paper in context of the first one.

https://www.pnas.org/content/118/41/e2106634118

https://www.nature.com/articles/s41575-021-00416-6

~ Amanda, Y@h00 RLFTF finance conversations

[changes_iv]

MYOCARDITIS???

Inflammation of the middle layer of the heart wall.

Myocarditis is usually caused by a viral infection. A severe case can weaken the heart, which can lead to heart failure, abnormal heartbeat, and sudden death.

PERICARDITIS???

A swelling and irritation of the thin saclike membrane surrounding the heart (pericardium).

Pericarditis may be caused by a viral infection or heart attack. In many cases, the cause is unknown.

~ MAYO CLINIC


Myocardial fibrosis is defined by a significant increase in the collagen volume of myocardial tissue. It is a complex process that involves all components of the myocardial tissue and can be triggered by tissue injury from myocardial ischemia (hypoxia), inflammation, and hypertensive overload.

~ Mayo Clinic Proceedings

We conclude that VIP [Vasoactive Intestinal Peptide] infusion increased myocardial VIP concentration and was able to reverse existing myocardial fibrosis suggesting a possible therapeutic role for a VIP based therapy in cardiac failure.

https://pubmed.ncbi.nlm.nih.gov/31449808/